Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV), the French biotech company, slipped 7% to 67p after confirming chief executive David Allmond will be stepping down with immediate effect.
Current chief financial officer James McCarthy will become acting CEO until a permanent successor is appointed, it said.
Allmond is leaving his role and the board to “pursue other business opportunities”.